Epinephrine auto-injector to be available to U.S. allergy patients in the first half of 2017.
Food Allergy News
Diner Who Almost Died in Salmon Allergy Mix-Up Suffers Backlash
Simon-Pierre Canuel speaks out about the painful criticism he faced after waiter’s arrest.
Shelf Life of EpiPen Auto-Injector May Grow to 2 Years
Mylan pursuing whether shelf life can increase to 24 months.
Mylan Says It Agrees to Pay $465 Million to End Medicaid Dispute
Lawmakers had charged EpiPen maker was significantly underpaying program.
Giorgi Family Reaches $15 Million Settlement in Allergy Tragedy
“It does actually allow us to know that we are doing good in our daughter’s name, and that carries her memory on.”
House Committee Presses Mylan for Paperwork on EpiPen Profits
Congress seeks numerous documents and explanation on tax-factoring.
Lawmakers Grill Mylan’s Bresch Over EpiPen Prices
Heather Bresch defends Mylan on prices and profits, while FDA is asked “where’s the competition?
No Criminal Charges for Quebec Waiter over Man’s Severe Allergic Reaction
A Quebec waiter who served salmon tartare to a customer with a life-threatening fish allergy will not face criminal negligence charges.
Activists Fear Backlash Could Harm Stock Epi Access, Leave Students Vulnerable
Mother-of-three Christina Casado had never heard of an epinephrine auto-injector, until the device was used to save her son’s life.
Inside the EpiPen Price Backlash
Amid a firestorm of controversy over price hikes on lifesaving EpiPens, drug manufacturer Mylan made a dramatic and unusual move this week – it announced the launch of a lower cost generic replica of its own brand-name epinephrine auto-injector.